| Net Cash Provided by (Used in) Operating Activities |
-4.2M |
USD |
+20.3% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
6.3M |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500M |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
40.3M |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
2.11M |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
12.5M |
USD |
-35.3% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
57.8M |
USD |
+3.64% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
59M |
USD |
+3.33% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
589K |
USD |
|
Q4 2024 |
FY 2024 |
| Depreciation |
80K |
USD |
+19.4% |
Q1 2025 |
Q1 2025 |
| Payments to Acquire Property, Plant, and Equipment |
50K |
USD |
|
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-364K |
USD |
+39.3% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
631K |
USD |
|
Q4 2024 |
FY 2024 |
| Property, Plant and Equipment, Gross |
803K |
USD |
|
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
313K |
USD |
|
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
318K |
USD |
|
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
313K |
USD |
|
Q4 2024 |
FY 2024 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.05 |
pure |
0% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
42K |
USD |
|
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
28.2M |
USD |
-0.51% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
4.79M |
USD |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
374M |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |